Inflammatory and Cerebrospinal Biochemical Markers in Blood During Prolonged Hyperbaric Exposure (Mättnad2017)

April 5, 2019 updated by: Anders Rosén, Sahlgrenska University Hospital, Sweden

Inflammatoriska Och Neurokemiska förändringar Vid ökat Omgivningstryck

Research hypothesis

  • Prolonged hyperbaric exposure will affect the central nervous system
  • Prolonged hyperbaric exposure will induce inflammatory changes
  • Prolonged hyperbaric exposure will affect fluid regulation in the body

Objectives:

  • To investigate the presence of cerebrospinal biochemical markers in blood during prolonged hyperbaric exposure
  • To investigate changes in the quantity of cerebrospinal biochemical markers in blood during decompression after prolonged hyperbaric exposure
  • To investigate the presence of inflammatory markers in blood during prolonged hyperbaric exposure
  • To investigate changes in the quantity of inflammatory markers in blood during decompression after prolonged hyperbaric exposure
  • To investigate if prolonged hyperbaric exposure alters fluid balance in the body

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

When diving with compressed air, a continuous accumulation of nitrogen will take place in the body. The total uptake of nitrogen by the tissues is dependent on the duration and depth of the performed dive. During prolonged exposure to hyperbaric conditions the body eventually will become saturated with nitrogen. In a hyperbaric environment corresponding to a depth of 30 meters seawater, nitrogen saturation could be expected after about 24 hours. Decompression can cause accumulated nitrogen to form intravascular bubbles.

It has long been considered that decompression sickness (DCS) is caused by bubble formation when dissolved nitrogen at the end of diving comes out of solution. Doppler ultrasound techniques have shown that intravascular gas bubbles could exist even after uneventful dives. Therefore, additional pathophysiological factors must be sought.

Dehydration is a common finding after diving in water. It is probably caused by a combination of a non-existent water intake during diving and a physiologically increased urine production, caused by the increased ambient pressure.

There is evidence of an increased inflammatory activity in blood after diving. Signs of neutrophil activation is a common finding. It is not known if hyperbaric exposure in itself is enough to elicit these biochemical changes or if the presence of intravascular nitrogen bubbles is needed.

Studies have shown that biochemical markers of central nervous system (CNS) injury can be detected in blood samples obtained from patients with DCS, metabolic and neurologic disease, during cardiac surgery and after traumatic brain injuries. Such markers can also be seen in blood after sport activities like boxing and breath hold diving. If biochemical markers of CNS injury will be present in blood after hyperbaric exposure is not known.

Diving is a common activity in society. It is practised both recreationally and professionally. The police, coast guard, emergency services and armed forces employ professional divers.

The Swedish armed forces (SwAF) Diving and Naval Medicine Center (DNC) is responsible for education and training of divers for SwAF. The centre is also responsible for research and development and conduct tests for diving medicine, and tests of underwater equipment.

SwAF DNC will during 2017 perform saturation diving tests in a dry chamber environment. The study "Inflammatory and cerebrospinal biochemical markers in blood during prolonged hyperbaric exposure - an observational controlled study" will be followed out during these tests. It entails venous blood sampling, spirometric testing and cardiac ultrasound.

This is a prospective, controlled observational study. The study aims to involve at least 16 study subjects. Half of the subjects (at least 8 persons), named the intervention group, will be exposed to hyperbaric conditions. The hyperbaric exposure is part of the Swedish navy saturation diving tests. Half of the subjects (at least 8 persons), named the control group, will experience no hyperbaric exposure.

The intervention group will be compressed in a dry hyperbaric chamber to 4 ATA and remain at that pressure for 36 hours. They will then be decompressed 0,5 meters/hour for 30 hours, after which they will be decompressed 0,375 meters/hour for 40 hours. After 70 hours of decompression normal atmospheric pressure will be reached and the subjects will leave the hyperbaric chamber. The oxygen partial pressure inside the chamber will be actively controlled and never exceed 50 kPa.

Members of the intervention group will be examined by a physician trained in diving medicine before and after the hyperbaric exposure. Spirometric testing of lung function will be carried out at both these occasions. Immmediately after hyperbaric exposure cardiac ultrasound will be used to assess presence and duration of VGE.

Five blood samples (6 mL blood each) will be obtained from all study subjects from both groups according to the following plan:

  • before compression commences
  • about one hour before decompression commences
  • within one hour after leaving the hyperbaric chamber
  • about 24 hours after leaving the hyperbaric chamber
  • if possible, about 5-7 days after leaving the hyperbaric chamber.

Blood samples are obtained from the control group at the same time points as from the intervention group.

In addition to above mentioned samples, blood samples (6 mL blood each) regarding fluid balance will be obtained from intervention group subjects before, during and after hyperbaric exposure.

Signs of DCS will be actively sought.

Study Type

Observational

Enrollment (Actual)

26

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gothenburg, Sweden, S-405 30
        • Gothenburg university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Submariners and divers employed by the Swedish navy and individuals approved by the Swedish navy for work in a hyperbaric environment participating in the Swedish navy saturation diving tests.

Submariners and divers employed by the Swedish navy and individuals approved by the Swedish navy for work in a hyperbaric environment not participating in the Swedish navy saturation diving tests.

Description

Inclusion Criteria:

  • Submariners and divers employed by the Swedish navy or individuals approved by the Swedish navy for work in a hyperbaric Environment.
  • Subjects in the intervention group must be participating in the Swedish navy saturation diving tests.

Exclusion Criteria:

- As this is a highly selected population there is no exclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Saturation
Individuals exposed to prolonged hyperbaric exposure
Hyperbaric exposure 4 ATA for 36 hours followed by 70 hours decompression
Control
Individuals not exposed to prolonged hyperbaric exposure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concentration of inflammatory and cerebrospinal biochemical markers in blood
Time Frame: 14 days
E. g: tau, NfL, GFAP, UCHL-1, VCAM-1, ICAM-1, Endothemin-1 and others
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemical signs of altered fluid balance in the body
Time Frame: 7 days
Hematocrit
7 days
Changes in lung function
Time Frame: 7 days
Spirometry (FVC, FEV, diffusing capacity)
7 days
Presence of Venous gas Emboli (VGE)
Time Frame: 7 days
Doppler and 2-D echocardiography
7 days
Decompression sickness (DCS)
Time Frame: 7 days
Clinical diagnosis
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 17, 2017

Primary Completion (ACTUAL)

January 17, 2018

Study Completion (ACTUAL)

January 17, 2018

Study Registration Dates

First Submitted

June 14, 2017

First Submitted That Met QC Criteria

June 16, 2017

First Posted (ACTUAL)

June 20, 2017

Study Record Updates

Last Update Posted (ACTUAL)

April 9, 2019

Last Update Submitted That Met QC Criteria

April 5, 2019

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Saturation Exposure

Clinical Trials on Hyperbaric exposure

3
Subscribe